Table 7.

Incremental cost-effectiveness ratio adjusting for comorbidity undiscounted. Cost specification 1.1000 DKK

	Without productivity loss		With productivity loss
	(0%, 25%)	(15%, 25%)	(0%, 25%)	(15%, 25%)
SMR 1, qCM 1 (no comorbidity)	53–118	319–803	0–105	72–553
SMR 1.5, qCM 0.9	72–159	397–997	0–142	98–686
SMR 2, qCM 0.8	94–208	460–1156	0–185	128–796

DKK Danish kroner, qCM comorbidity on quality of life, SMR standard mortality rate